Secondary Logo

Institutional members access full text with Ovid®

Short-Form Mindfulness-Based Stress Reduction Reduces Anxiety and Improves Health-Related Quality of Life in an Inner-City Population

Smith, Brad PhD; Metzker, Kathleen MPH; Waite, Roberta EdD, PMHCNS-BC, FAAN, ANEF; Gerrity, Patricia PhD, RN, FAAN

doi: 10.1097/HNP.0000000000000075

Mindfulness-based stress reduction is a mindfulness-based intervention that is an effective treatment modality for many conditions including stress, anxiety, and depression. Using data from 23 patients who completed a short-form mindfulness-based stress reduction course at a federally qualified health center, a quasi-experimental design was used to assess the impact of participation on self-reported anxiety, stress, mindfulness, and quality of life. Mindfulness and stress showed improvements from pre- to posttests, but neither difference achieved statistical significance. Participants showed statistically significant decreases in anxiety (7-item Generalized Anxiety Disorder scale score: 7.8-4.4; P = .005) and improvements in health-related quality of life including the 36-item Medical Outcomes Study Short Form Health Survey Mental Component Summary (+9.1; P = .001), Physical Functioning (+6.6; P = .039), Vitality (+16.1; P = .001), Social Functioning (+16.9; P = .003), Role Physical (+16.8; P = .016), and Mental Health (+15.6; P < .001) subscales. These findings suggest that an abbreviated mindfulness-based stress reduction course can serve to reduce anxiety and improve quality of life in an underserved population.

Stephen and Sandra Sheller 11th Street Family Health Services, Drexel University, Philadelphia, Pennsylvania.

Correspondence: Brad Smith, PhD, Stephen and Sandra Sheller 11th Street Family Health Services, Drexel University, 850 N 11th St, Philadelphia, PA 19123 (

Initial support for the Center's mind-body practitioner was generously provided by the Barra Foundation.

Dr Waite is a paid board member for CHE Trinity Health, and a paid consultant to Shire pharmaceuticals. For the remaining authors, no conflicts of interest were declared. None of the authors have a financial conflict of interest that impacts the data and analysis presented in this article.

© 2015 by Wolters Kluwer Health | Lippincott Williams & Wilkins